ロード中...
A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model
The blockade of programmed cell death-1 (PD1) and its ligand PDL1 has been proven to be a successful immunotherapy against several cancers. Similar to cancer, PD1 contributes to the establishment of several chronic infectious diseases, including malaria. While monoclonal antibodies (mAbs) targeting...
保存先:
| 出版年: | Front Immunol |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7363839/ https://ncbi.nlm.nih.gov/pubmed/32733457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01377 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|